Barclays analyst Matt Miksic raised the firm’s price target on Stryker (SYK) to $443 from $418 and keeps an Overweight rating on the shares. The firm updated the company’s projections to be in-line with its 2025 outlook.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker price target raised to $450 from $410 at Argus
- Stryker price target raised to $413 from $409 at Truist
- Alphatec likely to benefit as Stryker exits spinal implants, says Lake Street
- Stryker Corp’s Strong Earnings Call Highlights Growth and Strategy
- Stryker price target raised to $427 from $384 at Goldman Sachs